Eli Lilly Files 8-K with Q1 2026 Financials
Ticker: LLY · Form: 8-K · Filed: Apr 30, 2026 · CIK: 0000059478
| Field | Detail |
|---|---|
| Company | Eli Lilly &Amp; Co (LLY) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k, pharmaceuticals
TL;DR
Lilly dropped their Q1 2026 results, check the 8-K for the deets.
AI Summary
On April 30, 2026, Eli Lilly and Company filed an 8-K report detailing their financial results for the period ending April 30, 2026. The filing includes information on their Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
Why It Matters
This filing provides investors with the latest financial performance data for Eli Lilly, crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.
Key Players & Entities
- Eli Lilly & Company (company) — Filer of the 8-K report
- 0000059478 (company) — CIK number for Eli Lilly & Company
- 2026-04-30 (date) — Filing date and period of report
FAQ
What specific financial information is included in the 8-K filing?
The filing includes information related to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
When was this 8-K report filed and for what period?
The report was filed on April 30, 2026, for the period ending April 30, 2026.
What is the CIK number for Eli Lilly & Company?
The CIK number for Eli Lilly & Company is 0000059478.
What are the mailing and business addresses listed for Eli Lilly?
Both the mailing and business addresses are LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285.
What SIC code is associated with Eli Lilly & Company?
The SIC code associated with Eli Lilly & Company is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2026 regarding ELI LILLY & Co (LLY).